Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2017.00330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Is Functionally Essential in Myxoid Liposarcoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amino Acids Activate Mammalian Target of Rapamycin Complex 2 (mTORC2) via PI3K/Akt Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Putative Phosphatidylinositol 3-Kinase (PI3K) Binding Motifs in Ovine Betaretrovirus Env Proteins Are Not Essential for Rodent Fibroblast Transformation and PI3K/Akt Activation

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Shiga Toxin 1-Induced Proinflammatory Cytokine Production Is Regulated by the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2009English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway

Oncotarget
Oncology
2017English

PI3K/Akt-sensitive MEK-independent Compensatory Circuit of ERK Activation in ER-positive PI3K-mutant T47D Breast Cancer Cells

Cellular Signalling
Cell Biology
2010English

Class IB-Phosphatidylinositol 3-Kinase (PI3K) Deficiency Ameliorates IA-PI3K-Induced Systemic Lupus but Not T Cell Invasion

Journal of Immunology
AllergyImmunology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy